Product Name
SLC22A5, Polyclonal Antibody
Full Product Name
Anti-SLC22A5 Antibody
Product Gene Name
anti-SLC22A5 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for O76082
Species Reactivity
Human, Mouse, Rat
Specificity
Western blot analysis of extracts of various cell lines, using SLC22A5 antibody. Immunofluorescence analysis of MCF7 cell using SLC22A5 antibody. Blue: DAPI for nuclear staining.
Purity/Purification
Affinity Purification
Concentration
1mg/ml (lot specific)
Immunogen
Recombinant protein of human SLC22A5
Storage Buffer
PBS with 0.02% sodium azide,50% glycerol, pH7.3.
Preparation and Storage
Store at -20 degree C (regular) and -80 degree C (long term). Avoid freeze / thaw cycles.
Other Notes
Small volumes of anti-SLC22A5 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-SLC22A5 antibody
Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy.
Applications Tested/Suitable for anti-SLC22A5 antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Application Notes for anti-SLC22A5 antibody
WB: 1:500 - 1:2000
IHC: 1:50- 1:200
IF: 1:50- 1:200
Western Blot (WB) of anti-SLC22A5 antibody
Immunofluorescence (IF) of anti-SLC22A5 antibody
NCBI/Uniprot data below describe general gene information for SLC22A5. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001295051.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001308122.1
[Other Products]
UniProt Primary Accession #
O76082
[Other Products]
UniProt Secondary Accession #
Q6ZQZ8; Q96EH6; A2Q0V1; B2R844; D3DQ87[Other Products]
UniProt Related Accession #
O76082[Other Products]
Molecular Weight
65,327 Da
NCBI Official Full Name
solute carrier family 22 member 5 isoform a
NCBI Official Synonym Full Names
solute carrier family 22 member 5
NCBI Official Symbol
SLC22A5 [Similar Products]
NCBI Official Synonym Symbols
CDSP; OCTN2
[Similar Products]
NCBI Protein Information
solute carrier family 22 member 5
UniProt Protein Name
Solute carrier family 22 member 5
UniProt Synonym Protein Names
High-affinity sodium-dependent carnitine cotransporter; Organic cation/carnitine transporter 2
Protein Family
Solute carrier family
UniProt Gene Name
SLC22A5 [Similar Products]
UniProt Synonym Gene Names
OCTN2 [Similar Products]
NCBI Summary for SLC22A5
Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
UniProt Comments for SLC22A5
SLC22A5: Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without the involvement of sodium. Also relative uptake activity ratio of carnitine to TEA is 11.3. Defects in SLC22A5 are the cause of systemic primary carnitine deficiency (CDSP). CDSP is an autosomal recessive disorder of fatty acid oxidation caused by defective carnitine transport. Present early in life with hypoketotic hypoglycemia and acute metabolic decompensation, or later in life with skeletal myopathy or cardiomyopathy. Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral; Membrane protein, multi-pass; Transporter; Transporter, SLC family
Chromosomal Location of Human Ortholog: 5q31.1
Cellular Component: apical plasma membrane; brush border membrane; integral to plasma membrane; plasma membrane
Molecular Function: carnitine transporter activity; cation:cation antiporter activity; drug transporter activity; PDZ domain binding; protein binding; quaternary ammonium group transmembrane transporter activity
Biological Process: carnitine metabolic process; carnitine transport; drug transport; quaternary ammonium group transport; quorum sensing during interaction with host
Disease: Carnitine Deficiency, Systemic Primary
Research Articles on SLC22A5
1. The local genotype influences methylation levels at SLC22A5 and ZPBP2 promoters independently of the asthma status. Further studies are necessary to confirm the relationship between GSDMA-ZPBP2 and SLC22A5 methylation and asthma in females and males separately.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.